tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

FENC Stock Latest News

Fennec price target raised to $18 from $17 at H.C. Wainwright
The FlyFennec price target raised to $18 from $17 at H.C. Wainwright
15d ago
FENC
Fennec Pharmaceuticals Reports Strong 2023 Growth
PremiumCompany Announcements
Fennec Pharmaceuticals Reports Strong 2023 Growth
17d ago
FENC
Fennec participates in a conference call with Craig-Hallum
PremiumThe Fly
Fennec participates in a conference call with Craig-Hallum
22d ago
FENC
Fennec participates in a conference call with Craig-Hallum
PremiumThe Fly
Fennec participates in a conference call with Craig-Hallum
23d ago
FENC
Fennec participates in a conference call with Craig-Hallum
PremiumThe Fly
Fennec participates in a conference call with Craig-Hallum
27d ago
FENC
Fennec price target raised to $20 from $18 at Craig-Hallum
PremiumThe FlyFennec price target raised to $20 from $18 at Craig-Hallum
27d ago
FENC
Fennec Pharmaceuticals Files SEC 8-K Report
PremiumCompany Announcements
Fennec Pharmaceuticals Files SEC 8-K Report
28d ago
FENC
Fennec Pharmaceuticals’ Soaring Sales and New Deal
PremiumCompany Announcements
Fennec Pharmaceuticals’ Soaring Sales and New Deal
29d ago
FENC
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
29d ago
FENC
Fennec reports Q4 EPS (10c), consensus (2c)
PremiumThe Fly
Fennec reports Q4 EPS (10c), consensus (2c)
29d ago
FENC
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
PremiumPress Releases
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
1M ago
FENC
Fennec price target raised to $18 from $17 at Craig-Hallum
PremiumThe Fly
Fennec price target raised to $18 from $17 at Craig-Hallum
1M ago
FENC
Fennec Pharmaceuticals Strikes Major European Deal
PremiumCompany AnnouncementsFennec Pharmaceuticals Strikes Major European Deal
1M ago
FENC
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
PremiumPress Releases
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
1M ago
FENC
Fennec sees FY23 revenue $20.7M-$21.2M, consensus $19.57M
PremiumThe Fly
Fennec sees FY23 revenue $20.7M-$21.2M, consensus $19.57M
2M ago
FENC
Fennec sees Q4 revenue $9.2M-$9.7M, consensus $8.06M
PremiumThe Fly
Fennec sees Q4 revenue $9.2M-$9.7M, consensus $8.06M
2M ago
FENC
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
PremiumPress Releases
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
2M ago
FENC
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
PremiumPress Releases
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
3M ago
FENC
Fennec Announces Incremental $5 Million Investment from Petrichor
PremiumPress Releases
Fennec Announces Incremental $5 Million Investment from Petrichor
5M ago
FENC
Fennec files $90M common shares offering
PremiumThe FlyFennec files $90M common shares offering
5M ago
FENC
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
PremiumPress Releases
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
5M ago
FENC
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update
5M ago
FENC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >